Glycoxidation and lipoxidation in atherogenesis (Q34006261)

30 July 2017

1 reference

title

Glycoxidation and lipoxidation in atherogenesis (English)

1 reference

30 July 2017

Baynes JW

1

1 reference

PubMed ID

10946212

30 July 2017

Thorpe SR

series ordinal

2

1 reference

30 July 2017

1 June 2000

1 reference

Free Radical Biology and Medicine

30 July 2017

1 reference

30 July 2017

28

1 reference

30 July 2017

1708-1716

1 reference

30 July 2017

12

1 reference

Lipoprotein atherogenicity: an overview of current mechanisms

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Levuglandin E2-protein adducts in human plasma and vasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Protein-bound acrolein: potential markers for oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Glutathione (GSH) and the toxicity of oxidised low-density lipoprotein to human monocyte-macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Protein Aging by Carboxymethylation of Lysines Generates Sites for Divalent Metal and Redox Active Copper Binding: Relevance to Diseases of Glycoxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Lipoprotein glycation and its metabolic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Receptors for proteins modified by advanced glycation endproducts (AGE)--their functional role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Can antioxidant vitamins materially reduce oxidative damage in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900228-8

7 January 2021

10.1016/S0891-5849(00)00228-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10946212